Actinomycosis: the disease and its treatment. (1981 study) Skip to main content
Review Drug intelligence & clinical pharmacy 1981

Actinomycosis: the disease and its treatment.

Robbins TS, Scott SA, Drug intelligence & clinical pharmacy, 1981

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors described one patient with a lung infection caused by a bacterium called Actinomyces israelii and wrote a review of this rare disease and its treatment.

What They Found

This case report and review describes one man with pulmonary actinomycosis who had fever, weight loss, and a painful mass on his lower left rib cage. Tests on fluid drawn from the chest wall mass showed Actinomyces israelii as the infecting organism. The patient was treated successfully with long-term penicillin therapy. The abstract gives no sample size beyond this single case and no other figures. The review part covers the treatment of the disease and how it is similar to and different from other bacterial and fungal diseases.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a single-patient case report and narrative review from 1981, so it cannot show how well any treatment works in other patients.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Uncategorised
Source Pubmed
PubMed ID 7274029
Year Published 1981
Journal Drug intelligence & clinical pharmacy
MeSH Terms Actinomycosis; Adult; Clindamycin; Humans; Hyperbaric Oxygenation; Lincomycin; Lung Diseases; Male; Penicillins

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology